Onureg (azacitidine) is a prescription medicine used for continued treatment of adults with acute myeloid leukemia (AML) who:
had a first complete remission (CR) following intensive induction chemotherapy with or without recovery of your blood cell counts, and
who are not able to complete intensive curative therapy.
It is not known if Onureg is safe and effective in children under 18 years of age.
